Role of Synchronized Lifestyle Modification Program on Diabetic Peripheral Neuropathy Patients Taking Oral Hypoglycemics and GLP-1 Analogues

Registration

Registration

NCT04813146

Study type

INTERVENTIONAL

Allocation

RANDOMIZED

Masking

NONE

Status

COMPLETED

Enrollment

216

Start

2021-02-05

Primary completion

2022-01-30

Lead sponsor

Riphah International University

Conditions

Diabetic Neuropathies

Interventions

OTHER:SLP; OTHER:SLP along with Physiotherapy; OTHER:Physiotherapy

Results posted

FALSE

Individual participant data sharing

NO

Registered primary outcomes

• Life style pattern assessment [12 weeks]
• Calculation of Body Mass Index [12 weeks]
• Measurement of Systolic Blood pressure [12 weeks]
• Measurement of Diastolic Blood pressure [12 weeks]
• Michigan Neuropathy Screening Instrument [12 weeks]
• Peak latency of Sensory Nerves (Sural and Peroneal) [12 weeks]
• Amplitude of Sensory Nerves (Sural and Peroneal) [12 weeks]
• Velocity of Sensory Nerves [12 weeks]
• Onset Latency of Motor Nerves (Peroneal and Tibial) [12 weeks]
• Amplitude of Motor Nerves (Peroneal and Tibial) [12 weeks]
• Velocity of Motor Nerves (Peroneal and Tibial) [12 weeks]
• Assessment of Balance by Berg Balance Scale [12 weeks]
• Serum Fasting Blood Glucose [12 weeks]
• Serum Total Cholesterol [12 weeks]
• Serum Triglycerides [12 weeks]
• Serum High Density Lipoproteins (HDL) [12 weeks]
• Serum Low Density Lipoproteins [12 weeks]
• Serum HbA1c concentration [12 weeks]